Summary:
- Samsung and GRAIL, a healthcare company, have announced a strategic collaboration to bring GRAIL's Galleri multi-cancer early detection test to Asia.
- The Galleri test is a blood test that can detect over 50 types of cancer, often before symptoms appear, allowing for earlier treatment and better outcomes.
- This collaboration aims to make the Galleri test more accessible to people in Asia, potentially saving lives through early cancer detection.